Atherogenic versus non-atherogenic lipoprotein profiles in healthy individuals. is there a need to change our approach to diagnosing dyslipidemia?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Medicinal Chemistry

• Publication date

  2014-07-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/0929867321666140303153048PMID 24606516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Should low high-density lipoprotein cholesterol (HDL-C) be treated?

  2014cited by this paper
• Effect of Atorvastatin on Low-Density Lipoprotein Subpopulations and Comparison Between Indicators of Plasma Atherogenicity

  2014cited by this paper
• Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality.

  2014cited by this paper
• Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia?

  2013cited by this paper
• Increased Small Dense LDL and Decreased Paraoxonase Enzyme Activity Reveals Formation of an Atherogenic Risk in Streptozotocin-Induced Diabetic Guinea Pigs

  2013cited by this paper
• Association between small dense LDL and early atherosclerosis in a sample of menopausal women.

  2013cited by this paper
• Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum.

  2013cited by this paper
• Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A2 and carboxyl ester lipase lipases in atherosclerotic plaque formation

  2013cited by this paper
• Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study

  2012cited by this paper
• Lipid-lowering therapies and achievement of LDL-cholesterol targets

  2012cited by this paper
• Small dense LDL: An emerging risk factor for cardiovascular disease.

  2012cited by this paper
• How can we further improve the LDL-cholesterol target level achievement rate based on the Hungarian MULTI GAP 2011 study results and considering the new European dyslipidemia guidelines?

  2012cited by this paper
• Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?

  2012cited by this paper
• The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome

  2012cited by this paper
• Small dense LDL cholesterol is a robust therapeutic marker of statin treatment in patients with acute coronary syndrome and metabolic syndrome.

  2011cited by this paper
• Lipids, blood pressure, kidney – what was new in 2011?

  2011cited by this paper
• HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events.

  2011cited by this paper
• "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.

  2011cited by this paper
• HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.

  2011cited by this paper
• Atherogenic normolipidemia - a new phenomenon in the lipoprotein profile of clinically healthy subjects.

  2011cited by this paper
• Hyper-betalipoproteinemia LDL 1,2: a newly identified nonatherogenic hypercholesterolemia in a group of hypercholesterolemic subjects.

  2011cited by this paper
• Contribution of the atherogenic lipoprotein profile to the development of arterial hypertension.

  2011cited by this paper
• The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction.

  2010cited by this paper
• A modified formula for calculating low-density lipoprotein cholesterol values

  2010cited by this paper
• Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis.

  2009cited by this paper
• Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study

  2009cited by this paper
• Atherogenic lipid phenotype in a general group of subjects.

  2009cited by this paper
• The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

  2008cited by this paper
• Small Dense Low-Density Lipoproteins and Associated Risk Factors in Patients with Stroke

  2008cited by this paper
• Measurement of plasma oxidized low-density lipoprotein and its clinical implications.

  2007cited by this paper
• Low-density lipoprotein size and cardiovascular prevention.

  2006cited by this paper
• Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men: 13-Year Follow-Up Data From the Québec Cardiovascular Study

  2005cited by this paper
• Effect of Lipid-Lowering Drug Therapy on Small-Dense Low-Density Lipoprotein

  2005cited by this paper
• Effects of Atorvastatin and Simvastatin on Low-Density Lipoprotein Subtraction Profile, Low-Density Lipoprotein Oxidizability, and Antibodies to Oxidized Low-Density Lipoprotein in Relation to Carotid Intima Media Thickness in Familial Hypercholesterolemia

  2004cited by this paper
• Comparison of low-density lipoprotein size by polyacrylamide tube gel electrophoresis and polyacrylamide gradient gel electrophoresis.

  2003cited by this paper
• Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein.

  2003cited by this paper
• Gradient gel electrophoretic separation of LDL and HDL subclasses on BioRad Mini Protean II and size phenotyping in healthy Macedonians.

  2002cited by this paper
• Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200

  2002cited by this paper
• Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System.

  2001cited by this paper
• The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.

  1999cited by this paper
• Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins.

  1997cited by this paper
• Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

  1997cited by this paper
• Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.

  1993cited by this paper
• Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement.

  1992cited by this paper
• Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

  1990cited by this paper
• Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study.

  1988cited by this paper

• Short-Term Supplementation with 100% Bilberry Products and Its Effects on Body Composition and Lipid Profile in Overweight/Obese Women

  2025cites this paper
• Association of Atherogenic Index of Plasma with Cardiometabolic Risk Factors and Markers in Lean 14-to-20-Year-Old Individuals: A Cross-Sectional Study

  2023cites this paper
• Phytonutrients of Bitter Apricot Seeds Modulate Human Lipid Profile and LDL Subfractions in Adults with Elevated Cholesterol Levels

  2022cites this paper
• Metabolic syndrome – a new definition and management guidelines

  2022cites this paper
• Diabetic dyslipidaemia

  2021cites this paper
• The impact of sleep apnea syndrome on the altered lipid metabolism and the redox balance

  2021cites this paper
• Reduction of small dense LDL and Il-6 after intervention with Plantago psyllium in adolescents with obesity: a parallel, double blind, randomized clinical trial

  2021cites this paper
• Novel Therapeutical Approaches to Managing Atherosclerotic Risk

  2021cites this paper
• Gender differences in LDL and HDL subfractions in atherogenic and nonatherogenic phenotypes.

  2020cites this paper
• A pilot study on pattern B lipoprotein profile in Malaysia.

  2020cites this paper
• Dietary Fish Oil Concentrates Associated Health Benefits: A Recent Development of Cardiovascular Risk Reduction.

  2019cites this paper
• Effect of berries/apple mixed juice consumption on the positive modulation of human lipid profile

  2019cites this paper
• Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials

  2018cites this paper
• MULTIMARKER DIAGNOSTIC PANELS FOR ATHEROSCLEROSIS

  2018cites this paper
• Association between apolipoprotein E genotypes and panic disorder in Turkish population

  2018cites this paper
• Would Janus' view on HDL be useful?

  2018cites this paper
• Gender differences in LDL- and HDL-cholesterol subfractions in patients after the acute ischemic stroke and their association with oxidative stress markers

  2018cites this paper
• PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk.

  2017cites this paper
• The Assessment of a Nano-Delivery System for Increasing the Bioavailability and Efficacy of Lutein in Preventing Hepatic Steatosis and Systemic Inflammation in Guinea Pigs

  2016cites this paper
• Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients

  2016cites this paper
• [The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases].

  2016cites this paper
• Can the effects of gender, menopause and ageing on lipid levels be differentiated?

  2016cites this paper
• Compared with Powdered Lutein, a Lutein Nanoemulsion Increases Plasma and Liver Lutein, Protects against Hepatic Steatosis, and Affects Lipoprotein Metabolism in Guinea Pigs.

  2016cites this paper
• Influence of Atorvastatin on Plasma Atherogenic Biomarkers

  2016cites this paper
• Nutraceuticals in Lipid-Lowering Treatment

  2015cites this paper
• Editorial: current research, knowledge and controversies on high density lipoprotein.

  2014cites this paper
• Subfractions and subpopulations of HDL: an update.

  2014cites this paper
• A simple and effective approach for the treatment of dyslipidemia using anionic nanoliposomes.

  2014cites this paper